Filer Snapshot

John Richard Martin

CIK 0001715152. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

9

Latest filing

11 Jun 2024

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for Deciphera Pharmaceuticals, Inc.. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Insider / owner context

Deciphera Pharmaceuticals, Inc.

11 Jun 2024 ยท $0

Open owner page

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 11 Jun 2024 for CIK 0001715152.

View source filing
Business address
C/O Deciphera Pharmaceuticals, Inc., 200 Smith Stret, Waltham, MA, 02451

Filer intelligence

What SEC filings say about John Richard Martin

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for Deciphera Pharmaceuticals, Inc. worth $0.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

Deciphera Pharmaceuticals, Inc.

11 Jun 2024

$0

Latest update

What changed recently for John Richard Martin

Ownership report updated

Latest ownership report period: 11 Jun 2024. Open the source-backed page to inspect the fresh filing or facts context.

Update date

11 Jun 2024

Page type

Ownership filings

Latest period

11 Jun 2024

Ownership context was refreshed from SEC Forms 3/4/5 filed on 11 Jun 2024.

SEC filing record

CIK 0001715152 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
9
First seen
28 Sep 2017
Latest filing
11 Jun 2024
Entity
Individual

Observed form types

4 3/A 3

Latest Filings

Showing the latest 9 of 9 SEC filings for John Richard Martin.

4 File 001-38219

4

Filing date
11 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38219

FORM 4 SUBMISSION

Filing date
23 Jun 2023
Reporting date
21 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38219

FORM 4 SUBMISSION

Filing date
24 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38219

FORM 4 SUBMISSION

Filing date
25 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38219

FORM 4 SUBMISSION

Filing date
12 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38219

FORM 4 SUBMISSION

Filing date
13 Jun 2019
Reporting date
11 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38219

FORM 4 SUBMISSION

Filing date
21 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A File 001-38219

FORM 3/A SUBMISSION

Filing date
28 Mar 2018
Reporting date
27 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-38219

FORM 3 SUBMISSION

Filing date
28 Sep 2017
Reporting date
27 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .